Calcitonin Gene-related Peptide Receptor Antagonists [MoA] - N0000193918

Pharmacologic Code	N0000193918
Pharmacologic Name	Calcitonin Gene-related Peptide Receptor Antagonists
Pharmacologic Uses	calcitonin gene-related peptide receptor antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Calcitonin Gene-related Peptide Receptor Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0023-6498	Ubrelvy	Non-Proprietary Name: Ubrogepant	Tablet	Oral	Allergan, Inc.	ACTIVE
	0023-6501	Ubrelvy	Non-Proprietary Name: Ubrogepant	Tablet	Oral	Allergan, Inc.	ACTIVE
	0069-3500	Zavzpret	Non-Proprietary Name: Zavegepant	Spray	Nasal	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	0074-7094	Qulipta	Non-Proprietary Name: Atogepant	Tablet	Oral	Abbvie Inc.	ACTIVE
	0074-7095	Qulipta	Non-Proprietary Name: Atogepant	Tablet	Oral	Abbvie Inc.	ACTIVE
	0074-7096	Qulipta	Non-Proprietary Name: Atogepant	Tablet	Oral	Abbvie Inc.	ACTIVE
	63539-135	Zavzpret	Non-Proprietary Name: Zavegepant	Spray	Nasal	U.s. Pharmaceuticals	ACTIVE
	72618-3000	Nurtec Odt	Non-Proprietary Name: Rimegepant Sulfate	Tablet, Orally Disintegrating	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	72618-3001	Nurtec Odt	Non-Proprietary Name: Rimegepant Sulfate	Tablet, Orally Disintegrating	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE